Pros and Cons of Neonatal Screening for Cystic Fibrosis

  • Gerard J. te Meerman
  • Jeannette E. Dankert-Roelse
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 290)


In the past, several experimental schemes for neonatal screening for the presence of Cystic Fibrosis have been tried out. Several benefits of early detection have been claimed, but few studies are methodologically flawless, mainly because of the use of historical controls and/or a too short period of follow-up. At least initially, many programs suffered from the fact that after detection no systematic patient treatment scheme was available, and that no consensus was available on optimal treatment. The life expectancy of patients with cystic fibrosis has considerably improved over the last decades, mainly because better antibiotics became available and because treatment of complications has improved.


Cystic Fibrosis Prenatal Diagnosis Carrier Status Assortive Mating Neonatal Screening 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Rawls, J., 1972, A Theory of Justice. Oxford University PressGoogle Scholar
  2. Dankert-Roelse, J.E., G.J. te Meerman, A. Martijn, L.P. ten Kate, and K. Knol, 1989, Survival and clinical outcome in patients with cystic fibrosis, with and without neonatal screening, J. Ped., 114:362.CrossRefGoogle Scholar
  3. Lench N, P. Stanier, R. Williamson, 1988, Simple non-invasive method to obtain DNA for gene analysis, Lancet,ii:1356.CrossRefGoogle Scholar
  4. Gasparini P, A. Savoia, P.F. Pignatti, B. Dallapiccola, G. Novelli, 1989, Amplification of DNA from epithelial cells in urine, N. Eng. J. Med, 12:809.Google Scholar
  5. Feldman G.L., N. Lewiston, S.D. Fernbach, W.E. O’Brien, R. Williamson, B.J. Wainwright, and A.L. Beaudet, 1989, Prenatal diagnosis of cystic fibrosis by using linked DNA markers in 138 pregnancies at l-in-4 risk, Am. J. Med. Genet., 32:238.CrossRefGoogle Scholar
  6. Unnamed, Ethical issues policy statement on Huntington’s disease molecular genetics predictive test, 1990, J. Med. Genet., 27:34.Google Scholar
  7. Scheffer H., E. Verlind, D. Penninga, G.J. te Meerman, L.P. ten Kate, and C. Buys, 1989, Rapid screening for deltaF508 deletion in cystic fibrosis, Lancet, ii,1345.Google Scholar
  8. Bloch N, and N.R. Hayden, 1990, Predictive Testing for Huntington’s Disease in Childhood: Challenges and Implications, 1990, Am. J. Hum. Genet., 46:1.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Gerard J. te Meerman
    • 1
  • Jeannette E. Dankert-Roelse
    • 2
  1. 1.Department of Medical GeneticsUniversity of GroningenGroningenThe Netherlands
  2. 2.Department of PediatricsFree University of AmsterdamAmsterdamThe Netherlands

Personalised recommendations